News & Events
New Target for Treatment of Multiple Sclerosis?
A study published in the October, 2014 issue of Nature Medicine points to a new target for the treatment of multiple sclerosis (M.S.).
Circulating Tumor Cells Provide Genomic Snapshot of Breast Cancer
The genetic fingerprint of a metastatic cancer is constantly changing, which means that the therapy that may have stopped a patient’s cancer growth today, won’t necessarily work tomorrow.
MRSA Biofilms in Joint Fluid Make Infections Tough to Tackle; Pre-Treatment with Enzyme Prevents Formation
Thomas Jefferson University scientists, in collaboration with scientists at the National Institutes of Health, come one step closer to understanding why these infections are so tough to tackle. The results could help explain the joint pain caused by different infections, including Lyme disease and why they’re so resistant to antibiotic treatment.
Philadelphia College of Osteopathic Medicine Signs Affiliation Agreement with Jefferson
Members of Philadelphia College of Medicine (PCOM) faculty and staff recently met with representatives from Thomas Jefferson University’s School of Population Health to sign an affiliation agreement.
Center for Teaching & Learning is Open
Academic & Instructional Support & Resources (AISR) is now the Center for Teaching and Learning (CTL).
JMC Graduate Named CEO of Christiana Care
Jefferson Medical College alumni and former Department of Family and Community Medicine’s residency director, Janice Nevin, MD, named CEO of Christiana Care.
Jefferson Appoints Sang Hoon Woo, M.D., as Division Director of Hospital Medicine
Jefferson Appoints Sang Hoon Woo, M.D., as Division Director of Hospital Medicine.
Gobbling up Poison: a Method for Killing Colon Cancer
A new Immunotoxin works by getting shuttled into cancer cells, selectively destroying colon cancer, thanks to a quirk of biology
Watchful Waiting Isn’t Right for Everyone
African American men are one population that may be harmed by new guidelines that favor observation over treatment of early stage prostate cancer.
Follow the Doctor's Orders: Jefferson Cardiologists Underscore Long-Term Risks for Patients with Coronary Stents Who Discontinue Medications
In the September issue of the Journal of Invasive Cardiology, Jefferson cardiologists published a warning for physicians and patients alike about an alarming trend they are witnessing first hand – very, very late stent thrombosis.